Garden State Dispatch
SEE OTHER BRANDS

Following the news from New Jersey

Garden State Dispatch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Garden State Dispatch.

Press releases published on August 4, 2025

Verizon Gears Up for Back-to-School with a Weekend of Savings, Expert Advice & Essential Tech for Families

Verizon Gears Up for Back-to-School with a Weekend of Savings, Expert Advice & Essential Tech for Families

NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- As families prepare for the new school year, Verizon is launching a month of unmatched value and digital wellness support, kicking off with Verizon Family Weekend on August 9-10. During this weekend, Verizon …

Alexander’s Announces Second Quarter Financial Results

Alexander’s Announces Second Quarter Financial Results

PARAMUS, N.J., Aug. 04, 2025 (GLOBE NEWSWIRE) -- ALEXANDER’S, INC. (New York Stock Exchange: ALX) filed its Form 10-Q for the quarter ended June 30, 2025 today and reported: Second Quarter 2025 Financial Results Net income for the quarter ended June 30, …

2026 Identity & Payments Summit Issues Call for Speakers

2026 Identity & Payments Summit Issues Call for Speakers

REDWOOD CITY, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- The Secure Technology Alliance, the premier cross-industry association in digital security, today issues its call for speakers for the 2026 Identity …

Sonnet BioTherapeutics Expands Clinical Evaluation of SON-1010 Dose Escalation with Atezolizumab in Ovarian Cancer

Sonnet BioTherapeutics Expands Clinical Evaluation of SON-1010 Dose Escalation with Atezolizumab in Ovarian Cancer

Sonnet's lead product, SON-1010 (IL12-FHAB), is being evaluated in combination with atezolizumab (Tecentriq®) in patients with advanced platinum-resistant ovarian cancer (PROC) (SB221) Topline safety, cytokine, and efficacy data suggest a strong potential …

CareCloud’s TalkEHR Approved for Use by Critical Access Hospitals, Unlocking $1.5B+ Inpatient Market

CareCloud’s TalkEHR Approved for Use by Critical Access Hospitals, Unlocking $1.5B+ Inpatient Market

SOMERSET, N.J., Aug. 04, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leading provider of healthcare technology and generative AI solutions, today announced that its electronic health record (“EHR”) …

Aquestive Therapeutics to Report Second Quarter 2025 Financial Results and Recent Business Highlights on August 11 and Host Conference Call on August 12 at 8:00 a.m. ET

Aquestive Therapeutics to Report Second Quarter 2025 Financial Results and Recent Business Highlights on August 11 and Host Conference Call on August 12 at 8:00 a.m. ET

WARREN, N.J., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and …

Freshpet, Inc. Reports Second Quarter 2025 Financial Results

Freshpet, Inc. Reports Second Quarter 2025 Financial Results

Delivers Category Leading Growth Drives Operational Efficiencies that Deliver Margin Expansion and Reduce Capital Requirements Updates Outlook for 2025 and 2027 BEDMINSTER, N.J., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Freshpet, Inc. (“Freshpet” or the “Company …

Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling

Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling

RADNOR, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Certara, Inc., a global leader in biosimulation, today announced that the European Medicines Agency (EMA) has formally qualified the Simcyp® Simulator for use in regulatory submissions across the EU. Certara …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions